Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA burning sensation in the stomach is one of the more unsettling things people notice when they start Wegovy or increase their dose. It is real, it is common, and in most cases it reflects how semaglutide changes the way your gut works — not a sign that something has gone seriously wrong. That said, the same symptom can occasionally point to something that needs attention, so knowing the difference matters. Wegovy (semaglutide) is a GLP-1 receptor agonist licensed in the UK for weight management in adults; like all prescription-only medicines, it requires clinical assessment before a prescriber can decide whether it is right for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Many people assume that a burning stomach on Wegovy means the drug is irritating or damaging the stomach lining directly. It is an understandable worry, and it is largely not true. Semaglutide does not work by touching the stomach wall; it acts on GLP-1 receptors in the gut and brain, slowing the rate at which the stomach empties. Food, digestive enzymes and gastric acid all linger longer than they would normally. For most people, that delayed emptying is exactly what creates the burning or acidic feeling, it is the stomach's contents, not the medicine itself, that are causing the discomfort.
Acid reflux is another piece of the puzzle. When gastric emptying slows, the pressure in the stomach can push acid upwards into the lower oesophagus, producing the familiar burning that people often call heartburn. Both reflux and indigestion are listed as recognised side effects in the Wegovy prescribing information on the NHS semaglutide medicines page. Letting go of the idea that burning equals damage tends to make the experience feel a lot more manageable.
Practically, sitting upright for at least an hour after eating, reducing portion sizes and avoiding rich or fatty meals can take some of the edge off. None of this replaces a conversation with your prescriber, but these small adjustments often help in the first few weeks.
If you have been on Wegovy for a while and things were settling down, a sudden return of that burning sensation after moving to the next dose is not a sign the medicine has stopped agreeing with you. It is simply your gut adjusting again. Each upward step in the titration schedule asks your digestive system to adapt to a stronger effect on gastric motility.
The pattern tends to follow a recognisable arc: most noticeable in the first one to two weeks after the change, then easing as the body finds a new normal. Our prescribers hear this from patients regularly. The same logic applies if you had a break from treatment and restarted, the gut can react as though it is encountering the medicine for the first time.
If you are finding that burning or nausea is making it hard to eat enough, it is worth flagging with whoever is managing your treatment rather than waiting it out in silence. Some people find that slowing down the titration pace, staying a little longer at the current dose, helps considerably. That is a clinical decision, not one to make unilaterally, and it is exactly the kind of thing that aftercare support exists for. You can read more about what stomach discomfort on Wegovy typically involves, including the range of burning skin sensations some people notice on Wegovy, on our Wegovy stomach pain guide.
The January 2026 MHRA Drug Safety Update drew attention to acute pancreatitis as a known but infrequent serious risk associated with GLP-1 medicines. The symptoms that should prompt you to seek urgent medical help are: severe stomach pain that comes on quickly, persists rather than coming and going, and reaches through to the back, particularly if vomiting accompanies it. This is a different beast from the dull, acidic burning that characterises normal GI adjustment. If you experience that combination, do not try to manage it at home.
Gallbladder problems are another consideration. Rapid weight loss and the effect of GLP-1 medicines on the gallbladder can increase the risk of gallstones; pain in the upper right abdomen, often after eating, can point to this. Signs of dehydration from prolonged vomiting or diarrhoea (dizziness, very dark urine, inability to keep fluids down) also need prompt attention.
For unexpected or new types of stomach discomfort, the right steps are: contact your prescribing team, your GP, or NHS 111 depending on severity. Suspected side effects can also be reported directly via the MHRA Yellow Card scheme, which helps build the post-market safety picture for all GLP-1 medicines. Our guide to Wegovy and stomach flu symptoms covers the dehydration question in more detail.
For the ordinary, adjustment-related burning (the kind that peaks in week one of a new dose and then quietens down) there are some straightforward things that help. Eating smaller meals more slowly gives the stomach less to hold at once. Cold or room-temperature food often provokes less acid than very hot dishes. Reducing alcohol and caffeine during the adjustment window tends to reduce reflux. Some people find that lying down within an hour or two of eating makes things worse; a short walk instead of the sofa makes a tangible difference.
Over-the-counter antacids can provide short-term relief, but check with your pharmacist or prescriber before using them regularly alongside Wegovy, particularly because oral medicines can be affected by changes in gastric motility. For context on how the cost of private treatment sits alongside what you are getting in terms of clinical support and aftercare, our Wegovy price comparison guide covers what to look for.
If the burning does not ease within two to three weeks of a dose step, or if it is severe enough to affect your ability to eat or drink normally, that is a conversation for your prescriber rather than a symptom to push through. The Wegovy treatment overview has a broader look at what to expect across the course of treatment. When you are ready to explore whether treatment is right for you, our clinical team at nume (sorry, at nume) reviews every consultation personally. Start your free consultation and a GPhC-registered prescriber will read your answers the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.